← Back to Search

Therapeutic Evaluative Conditioning for Suicidal Thoughts and Behaviors (TEC Trial)

N/A
Recruiting
Led By Alexander Millner, PhD
Research Sponsored by Franciscan Hospital For Children, INC.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during inpatient hospitalization (average 14 days), plus an additional two months post- hospitalization.
Awards & highlights

TEC Trial Summary

This trial proposes a brief, scalable intervention to reduce suicide risk among adolescents during and after hospitalization, which could result in large-scale decreases in suicide death.

Who is the study for?
This trial is for adolescents aged 12-19 who are patients at the McLean-Franciscan Child and Adolescent Inpatient Program, have experienced self-harm or suicidal thoughts, can assent to participate, own a smartphone, and have parental permission. It excludes those heading to long-term residential care post-discharge or with cognitive impairments that prevent full participation.Check my eligibility
What is being tested?
The study tests a brief intervention called Therapeutic Evaluative Conditioning against a neutral condition to reduce suicidal thoughts and behaviors in hospitalized adolescents. The goal is to find an easily scalable method that could significantly lower suicide risks during the critical period after hospitalization.See study design
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, traditional side effects like you might see with drugs aren't expected. However, participants may experience emotional discomfort due to discussing sensitive topics.

TEC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during inpatient hospitalization (average 14 days), plus an additional two months post- hospitalization.
This trial's timeline: 3 weeks for screening, Varies for treatment, and during inpatient hospitalization (average 14 days), plus an additional two months post- hospitalization. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-injurious thoughts and behaviors

TEC Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active intervention armActive Control1 Intervention
Participants will complete the intervention on a mobile device.
Group II: Control armPlacebo Group1 Intervention
Participants will complete the sham comparator on a mobile device.

Find a Location

Who is running the clinical trial?

Franciscan Hospital For Children, INC.Lead Sponsor
Harvard UniversityOTHER
230 Previous Clinical Trials
474,470 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,554 Total Patients Enrolled
5 Trials studying Suicide Attempt
28,921 Patients Enrolled for Suicide Attempt

Media Library

Therapeutic Evaluative Conditioning Clinical Trial Eligibility Overview. Trial Name: NCT05796531 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research include people who are aged 60 or older?

"This clinical trial welcomes participants aged 12 or above and under 19."

Answered by AI

How many individuals is the capacity of this trial?

"Affirmative. By consulting clinicaltrials.gov, one can ascertain that this research project is still accepting participants since its initial posting on March 31st 2023 and latest re-evaluation of July 15th 2023. A total of 155 individuals need to be enrolled from 1 medical centre in order for the trial to continue."

Answered by AI

What qualifications do participants need to meet in order to join this research trial?

"Successful applicants to this medical trial must have attempted suicide and be in the age range of 12-19. This research project is aiming for around 155 participants."

Answered by AI

Are there still openings for those wishing to join the experiment?

"Affirmative. This medical study is still seeking out participants, as indicated by the information available on clinicaltrials.gov. It was first posted on March 31st 2023 and its most recent update happened in July 15th of the same year. 155 patients are required at a single location to carry out this trial successfully."

Answered by AI
~83 spots leftby Aug 2025